Fresenius SE & Co KGaA (FRE) Given a €53.00 Price Target at Jefferies Financial Group

Share on StockTwits

Jefferies Financial Group set a €53.00 ($61.63) target price on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Thursday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research analysts have also recently weighed in on the stock. Barclays set a €52.00 ($60.47) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Tuesday, April 30th. Deutsche Bank set a €65.00 ($75.58) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Friday, April 26th. HSBC set a €58.00 ($67.44) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Thursday, April 25th. Berenberg Bank set a €70.95 ($82.50) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Wednesday, April 24th. Finally, Morgan Stanley set a €45.00 ($52.33) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Tuesday, April 16th. Ten equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Fresenius SE & Co KGaA has an average rating of Buy and an average price target of €59.23 ($68.88).

Shares of FRE stock traded up €0.68 ($0.79) during trading on Thursday, reaching €51.43 ($59.80). The company’s stock had a trading volume of 1,792,419 shares. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

See Also: Initial Public Offering (IPO)

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.